C. Rexroth
4 Papers
C. Rexroth is an academic researcher. The author has contributed to research in topics: Drug & Medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder.
Elvira Tini,Lukasz Smigielski,Marcel Romanos,Christoph Wewetzer,Andreas Karwautz,Karl Reitzle,Christoph U. Correll,Paul L. Plener,Uwe Malzahn,Peter U. Heuschmann,Stefan Unterecker,Maike Scherf-Clavel,Hans Rock,Gisela Antony,Wolfgang Briegel,Christian Fleischhaker,Tobias Banaschewski,Tobias Hellenschmidt,Hartmut Imgart,Michael Kaess,Michael Kölch,Tobias J. Renner,S. Reuter-Dang,C. Rexroth,Gerd Schulte-Körne,Frank M. Theisen,Stefanie Fekete,Regina Taurines,Manfred Gerlach,Karin Egberts,Susanne Walitza +30 more
TL;DR: In this paper , the relationship between pharmacokinetics, pharmacodynamics, efficacy, and tolerability of sertraline across indications, particularly in non-adult patients, is not fully understood.
24
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorder
Emanuela Tini,Lukasz Smigielski,Marcel Romanos,Christoph Wewetzer,A. Karwautz,Karl Reitzle,Christoph U. Correll,Paul L. Plener,Uwe Malzahn,P. Heuschmann,Stefan Unterecker,Maike Scherf-Clavel,Hans Rock,Gisela Antony,Wolfgang Briegel,Christian Fleischhaker,Tobias Banaschewski,Tobias Hellenschmidt,Hartmut Imgart,Michael Kaess,Michael Kölch,T. Renner,S. Reuter-Dang,C. Rexroth,Gerd Schulte-Körne,Frank M. Theisen,Stefanie Fekete,Regina Taurines,Marie Gerlach,Karin Egberts,Susanne Walitza +30 more
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice
Karin Egberts,Manfred Gerlach,Christoph U. Correll,Paul L. Plener,Uwe Malzahn,Peter U. Heuschmann,Stefan Unterecker,Maike Scherf-Clavel,Hans Rock,Gisela Antony,Wolfgang Briegel,Christian Fleischhaker,Alexander Häge,Tobias Hellenschmidt,Harmut Imgart,Michael Kaess,Andreas Karwautz,Michael Kölch,Karl Reitzle,Tobias J. Renner,S. Reuter-Dang,C. Rexroth,Gerd Schulte-Körne,Frank M. Theisen,Susanne Walitza,Christoph Wewetzer,Stefanie Fekete,Regina Taurines,Marcel Romanos +28 more
TL;DR: Off-label use of antidepressants and antipsychotics in youth was not a risk factor for the occurrence of serious ADRs in a closely monitored clinical setting as evaluated in the ‘Therapeutic Drug Monitoring-VIGIL’ study.
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
Michael Frey,Lukasz Smigielski,Elvira Tini,Stefanie Fekete,Christian Fleischhaker,Christoph Wewetzer,Andreas Karwautz,Christoph U. Correll,Manfred Gerlach,Regina Taurines,Paul L. Plener,Uwe Malzahn,Selina Kornbichler,L. Weninger,Matthias Brockhaus,S. Reuter-Dang,Karl Reitzle,Hans Rock,Hartmut Imgart,Peter Heuschmann,Stefan Unterecker,Wolfgang Briegel,Tobias Banaschewski,Jörg M. Fegert,Tobias Hellenschmidt,Michael Kaess,Michael Kölch,Tobias J. Renner,C. Rexroth,Susanne Walitza,Gerd Schulte-Körne,Marcel Romanos,Karin Egberts +32 more
TL;DR: A clear linear dose–serum level relationship for fluoxetine in youth is demonstrated, with the identified reference range being within that established for adults.